Ignite Creation Date:
2024-05-06 @ 8:11 AM
Last Modification Date:
2024-10-26 @ 11:57 AM
Study NCT ID:
NCT02689362
Status:
COMPLETED
Last Update Posted:
2018-08-14
First Post:
2016-02-10
Brief Title:
Evogliptin in Type 2 Diabetes Mellitus EVOLUTION EVOgLiptina no Diabetes Mellitus TIpO 2
Sponsor:
Eurofarma Laboratorios SA
Organization:
Eurofarma Laboratorios SA
Organization Data
Organization:
Eurofarma Laboratorios SA
Class:
INDUSTRY
Study ID:
EF144
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Eurofarma Laboratorios SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None